171 related articles for article (PubMed ID: 12937225)
21. Association of interleukin-1 receptor antagonist gene polymorphism with IgA nephropathy.
Watanabe M; Iwano M; Akai Y; Kurioka H; Nishitani Y; Harada K; Hamano K; Shiiki H
Nephron; 2002 Aug; 91(4):744-6. PubMed ID: 12138282
[TBL] [Abstract][Full Text] [Related]
22. Serum GDIgA1 levels in children with IgA nephropathy and Henoch-Schönlein nephritis.
Mizerska-Wasiak M; Gajewski Ł; Cichoń-Kawa K; Małdyk J; Dziedzic-Jankowska K; Leszczyńska B; Rybi-Szumińska A; Wasilewska A; Pukajło-Marczyk A; Zwolińska D; Bieniaś B; Sikora P; Szczepańska M; Stelmaszczyk-Emmel A; Górska E; Pańczyk-Tomaszewska M
Cent Eur J Immunol; 2018; 43(2):162-167. PubMed ID: 30135628
[TBL] [Abstract][Full Text] [Related]
23. Clinical manifestations of Henoch-Schönlein purpura nephritis and IgA nephropathy: comparative analysis of data from the Japan Renal Biopsy Registry (J-RBR).
Komatsu H; Fujimoto S; Yoshikawa N; Kitamura H; Sugiyama H; Yokoyama H
Clin Exp Nephrol; 2016 Aug; 20(4):552-560. PubMed ID: 26456327
[TBL] [Abstract][Full Text] [Related]
24. [A clinico-pathological comparison between Henoch-Schonlein purpura nephritis and IgA nephropathy in children].
Guo HX; Zhang JJ; Shi PP; Fu SQ; Zhang LG; Wang M; Lu FX
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jul; 14(7):506-9. PubMed ID: 22809602
[TBL] [Abstract][Full Text] [Related]
25. Clinico-pathological association of Henoch-Schoenlein purpura nephritis and IgA nephropathy in children.
Mao S; Xuan X; Sha Y; Zhao S; Zhu C; Zhang A; Huang S
Int J Clin Exp Pathol; 2015; 8(3):2334-42. PubMed ID: 26045740
[TBL] [Abstract][Full Text] [Related]
26. VCAM-1, ICAM-1, and E-selectin in IgA nephropathy and Schönlein-Henoch syndrome: differences between tissue expression and serum concentration.
Mrowka C; Heintz B; Sieberth HG
Nephron; 1999; 81(3):256-63. PubMed ID: 10050078
[TBL] [Abstract][Full Text] [Related]
27. Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study.
Calvo-Río V; Loricera J; Martín L; Ortiz-Sanjuán F; Alvarez L; González-Vela MC; González-Lamuño D; Mata C; Gortázar P; Rueda-Gotor J; Arias M; Peiró E; Martínez-Taboada VM; González-Gay MA; Blanco R
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S45-51. PubMed ID: 23663681
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of prednisone treatment in children with IgA nephropathy and Schönlein-Henoch nephropathy according to the Waldo protocol with regard to pathomorphologic changes in renal biopsy].
Szymanik-Grzelak H; Mizerska-Wasiak M; Roszkowska-Blaim M
Pol Merkur Lekarski; 2001 Apr; 10(58):259-62. PubMed ID: 11434171
[TBL] [Abstract][Full Text] [Related]
29. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
[TBL] [Abstract][Full Text] [Related]
30. What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?
Davin JC; Ten Berge IJ; Weening JJ
Kidney Int; 2001 Mar; 59(3):823-34. PubMed ID: 11231337
[TBL] [Abstract][Full Text] [Related]
31. Morphometric comparison of the density of the mesangial deposits in idiopathic IgA-nephropathy and Schoenlein-Henoch nephritis. An ultrastructural study.
Danilewicz M; Wagrowska-Danilewicz M
Rocz Akad Med Bialymst; 1997; 42 Suppl 2():7-11. PubMed ID: 9646676
[TBL] [Abstract][Full Text] [Related]
32. Use of liquid chromatography-tandem mass spectrometry to perform urinary proteomic analysis of children with IgA nephropathy and Henoch-Schönlein purpura nephritis.
Fang X; Lu M; Xia Z; Gao C; Cao Y; Wang R; Wang M; Wu H
J Proteomics; 2021 Jan; 230():103979. PubMed ID: 32932007
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of renal clinicopathological changes in IgA nephropathy by urinary podocytes excretion and podocalyxin expression.
Jiang WL; Peng YM; Liu YH; Liu H; Chen GC; Xu XQ; Zhu XJ; Liu FY
Ren Fail; 2012; 34(7):821-6. PubMed ID: 22679920
[TBL] [Abstract][Full Text] [Related]
34. Activated complement C3: a potentially novel predictor of progressive IgA nephropathy.
Zwirner J; Burg M; Schulze M; Brunkhorst R; Götze O; Koch KM; Floege J
Kidney Int; 1997 Apr; 51(4):1257-64. PubMed ID: 9083294
[TBL] [Abstract][Full Text] [Related]
35. Immune complexes in acute adult-onset Henoch-Schonlein nephritis.
Hilhorst M; van Paassen P; van Breda Vriesman P; Cohen Tervaert JW
Nephrol Dial Transplant; 2011 Dec; 26(12):3960-7. PubMed ID: 21441402
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis inhibitor of macrophage as a biomarker for disease activity in Japanese children with IgA nephropathy and Henoch-Schönlein purpura nephritis.
Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Tasaki Y; Ohta K; Yachie A; Wada T
Pediatr Res; 2021 Feb; 89(3):667-672. PubMed ID: 32408340
[TBL] [Abstract][Full Text] [Related]
37. Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis.
Hara M; Yanagihara T; Kihara I
Clin J Am Soc Nephrol; 2007 Mar; 2(2):231-8. PubMed ID: 17699418
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies.
Gottsäter A; Forsblad J; Mätzsch T; Persson K; Ljungcrantz I; Ohlsson K; Lindgärde F
J Intern Med; 2002 Jan; 251(1):61-8. PubMed ID: 11851866
[TBL] [Abstract][Full Text] [Related]
39. Effect of acute hyperglycaemia on selected plasma and urinary cytokine antagonists in Type 1 diabetes mellitus.
Pelikánová T; Simková R; Tesar V; Jirsa M
Diabetologia; 2003 Apr; 46(4):470-4. PubMed ID: 12679866
[TBL] [Abstract][Full Text] [Related]
40. Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis.
Allen AC; Willis FR; Beattie TJ; Feehally J
Nephrol Dial Transplant; 1998 Apr; 13(4):930-4. PubMed ID: 9568852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
